Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fry

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Mini Reviews in Medicinal Chemistry|October 5, 2006
Utilizing peptide structures as keys for unlocking challenging targetsDavid Fry, Hongmao Sun
Current Topics in Medicinal Chemistry|June 23, 2007
Molecular modeling of melanocortin receptorsHongmao Sun, David Fry
BMC Palliative Care|August 8, 2025
Key themes and approaches in palliative and end-of-life care education for the general public: a systematic reviewMuzeyyen Seckin, Rumandeep Tiwana, David Fry, et al.
International Journal of Older People Nursing|November 5, 2024
Implementation and Impact of a Lifting Cushion for Care Home Residents Who Have FallenRianne Houghton, Fiona Cowdell, David Fry, et al.
Cancer|April 25, 2003
Combination therapy with irinotecan and protein kinase C inhibitors in malignant gliomaThomas C Chen, Susan Su, David Fry, et al.
Human Molecular Genetics|September 29, 2016
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseMaria Manczak, Ramesh Kandimalla, David Fry, et al.
Molecules (Basel, Switzerland)|November 27, 2025
Assessment of ADC Higher Order Structure Through 2D NMR AnalysisEmily M Grasso, Angela N Marquard, Zachary Sparta, et al.
Human Molecular Genetics|February 8, 2017
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, David Fry, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
N-acyl-L-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformationLi Chen, Jefferson Tilley, Richard V Trilles, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonistsLi Chen, Richard Trilles, Dorota Miklowski, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Mini Reviews in Medicinal Chemistry|October 5, 2006
Utilizing peptide structures as keys for unlocking challenging targetsDavid Fry, Hongmao Sun
Current Topics in Medicinal Chemistry|June 23, 2007
Molecular modeling of melanocortin receptorsHongmao Sun, David Fry
BMC Palliative Care|August 8, 2025
Key themes and approaches in palliative and end-of-life care education for the general public: a systematic reviewMuzeyyen Seckin, Rumandeep Tiwana, David Fry, et al.
International Journal of Older People Nursing|November 5, 2024
Implementation and Impact of a Lifting Cushion for Care Home Residents Who Have FallenRianne Houghton, Fiona Cowdell, David Fry, et al.
Cancer|April 25, 2003
Combination therapy with irinotecan and protein kinase C inhibitors in malignant gliomaThomas C Chen, Susan Su, David Fry, et al.
Human Molecular Genetics|September 29, 2016
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseMaria Manczak, Ramesh Kandimalla, David Fry, et al.
Molecules (Basel, Switzerland)|November 27, 2025
Assessment of ADC Higher Order Structure Through 2D NMR AnalysisEmily M Grasso, Angela N Marquard, Zachary Sparta, et al.
Human Molecular Genetics|February 8, 2017
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's diseaseRamesh Kandimalla, Maria Manczak, David Fry, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
N-acyl-L-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformationLi Chen, Jefferson Tilley, Richard V Trilles, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonistsLi Chen, Richard Trilles, Dorota Miklowski, et al.
Pageof 3